GEODIS Opens Dual Pharma Hubs in US and UK
GEODIS has launched two dedicated pharmaceutical cold chain facilities within weeks of each other. The forwarder opened a 5,200-square-foot temperature-controlled addition to its 78,000-square-foot Chicago container freight station near O’Hare International Airport. In parallel, GEODIS announced a 2,000-pallet GDP-compliant warehouse near Manchester Airport, scheduled to go live 1 June 2026.
Both sites target the same gap: short-term, high-compliance storage and cross-docking for temperature-sensitive healthcare cargo moving through air and ocean networks. Chicago marks GEODIS’s first U.S. location combining IATA CEIV Pharma certification with on-site cold storage capacity. Manchester extends the company’s existing European pharma network, which already includes facilities in France, the Netherlands, and Germany.
The Chicago facility is a certified cargo screening facility for exports and operates as a bonded CFS. Manchester sits close to the M6 and M62 motorways, enabling rapid distribution across the UK and direct airfreight connectivity through one of Europe’s busiest cargo airports.
Temperature Zones and Compliance Standards
The Chicago cold chain addition splits 5,200 square feet into two zones: 4,600 square feet at 15-25°C (controlled room temperature) and 600 square feet at 2-8°C (refrigerated). The deep cold storage zone offers 27 feet of clear ceiling height. Manchester mirrors this temperature structure across 2,000 pallet positions, with the option to add frozen storage if demand requires it.
Both sites meet GDP (Good Distribution Practice) and WDA pharmaceutical compliance standards. Manchester holds ISO 9001, ISO 14001, ISO 45001, ISO 50001, TAPA, AEO, and Dangerous Goods certifications. Chicago achieved CEIV Pharma accreditation, joining GEODIS branches in Atlanta, New York, and Los Angeles in holding the certification. All four U.S. sites now offer CEIV-certified handling, though only Chicago pairs it with dedicated cold storage.
Temperature monitoring runs 24/7 at both locations, with alert systems triggering if conditions drift outside validated ranges. A warehouse management system at Manchester provides barcode scanning, batch traceability, and real-time inventory visibility. Chicago operates as a high-velocity transshipment hub rather than long-term storage, matching the cross-dock model GEODIS uses across its European pharma network.
Strategic Location Selection
GEODIS chose Chicago because O’Hare is a major U.S. gateway for global air and ocean freight. The site serves as a transshipment point for pharmaceutical cargo entering or leaving North America, with short dwell times and tightly controlled handoffs between transport modes. Manchester offers similar logic: proximity to a large airport, strong motorway links, and a thriving life sciences sector across the Northwest of England and broader UK market.
“This new facility allows us to provide highly reliable end-to-end solution for temperature-sensitive healthcare products,” said Paul Morris, head of pharma and healthcare vertical for GEODIS in the UK. “With advanced monitoring systems, compliance standards and strong connectivity across the UK, we are well positioned to support pharmaceutical and biotech companies with safe, efficient and scalable logistics solutions.”
Josh Jungwirth, executive vice president of freight forwarding, Americas, at GEODIS, said the Chicago launch “demonstrates our commitment to the integrity and efficacy of the life-saving products we handle. By providing full visibility and internal control within our growing network of certified sites, we ensure that these sensitive air and ocean shipments are protected every step of the way. In the healthcare vertical, the stakes are uniquely high-at the end of every supply chain we manage is a patient.”
Sustainability and Operational Features
Both facilities incorporate energy-efficient refrigeration systems and LED lighting. Manchester includes waste-reduction initiatives as part of its design. GEODIS has not disclosed capital investment figures for either site, but the dual launch signals a clear bet on sustained growth in pharmaceutical cold chain volumes.
The Manchester warehouse supports both inventory management and cross-docking operations, giving clients flexibility depending on shipment urgency and distribution strategy. Chicago focuses on rapid transshipment, reflecting the faster pace and shorter dwell times typical of air cargo versus ocean freight.
Industry Context: Pharma Cold Chain Expansion
GEODIS’s investment mirrors broader moves across the healthcare logistics sector. Kuehne + Nagel recently opened a temperature-controlled facility in Hyderabad. Qatar Airways Cargo launched Pharma Passive FlexTemp, a new passive-cooling solution for pharmaceutical shipments. Envirotainer appointed a new CEO in May 2026 as it scales active temperature-control container capacity.
For freight forwarders competing in this vertical, the barrier to entry keeps rising. GDP compliance, CEIV certification, validated monitoring systems, and infrastructure investment all require capital and operational discipline. Smaller forwarders without dedicated pharma facilities increasingly rely on digital booking platforms to compare rates and secure capacity from certified partners across multiple trade lanes.
The pharma cold chain market rewards scale and reliability. GEODIS operates across 170 countries, giving it the network density to offer end-to-end temperature control on complex multi-leg routes. But independent forwarders can still compete by using open-access tools that connect them to vetted partners with the right certifications and capacity on specific lanes.
Frequently Asked Questions
What temperature ranges do the GEODIS pharma facilities maintain?
Both Chicago and Manchester facilities operate two primary temperature zones: controlled room temperature at 15-25°C and chilled environments at 2-8°C. Manchester also offers the option for frozen storage if required by client demand.
When does the Manchester pharma warehouse open?
The Manchester facility is scheduled to go live on 1 June 2026. It will offer 2,000 pallet positions for temperature-controlled pharmaceutical storage and cross-docking operations.
What is CEIV Pharma certification?
CEIV Pharma is an IATA certification programme that validates an organisation’s ability to handle temperature-sensitive pharmaceutical cargo according to international standards. It covers training, processes, and facility requirements to ensure cold chain integrity.
How many GEODIS U.S. locations have CEIV Pharma certification?
Four GEODIS branches in the United States hold CEIV Pharma certification: Chicago, Atlanta, New York, and Los Angeles. Chicago is the first of these four to combine the certification with dedicated on-site cold storage capacity.
Why are pharmaceutical cold chain facilities important for freight forwarders?
Pharmaceutical products often require strict temperature control to maintain efficacy and comply with regulatory standards. Cold chain facilities with GDP compliance, real-time monitoring, and CEIV certification enable forwarders to handle high-value, time-sensitive healthcare cargo without risking product integrity or facing compliance penalties.
What This Means for Freight Forwarders
Temperature-controlled pharmaceutical logistics is no longer a niche vertical. It’s a growth sector with strict compliance requirements and high client expectations. Large forwarders with dedicated cold chain infrastructure hold an advantage, but the market remains accessible to independent operators who can source capacity from certified partners and deliver reliable execution.
Cargo Solutions Network connects freight forwarders to vetted partners across 85 countries, including those with pharma-certified facilities and cold chain capacity. Quote complex multi-leg routes in minutes, compare airport-to-airport and door-to-door options, and book directly without subscription fees. Built by freight people, for freight people. Start quoting today at cargosolutionsnetwork.com-completely free to use.
